Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bio-Techne Corp shares valued at $122,691 were sold by Herr Amy E. on Feb 14 ’25. At $65.96 per share, Herr Amy E. sold 1,860 shares. The insider’s holdings dropped to 1,976 shares worth approximately $95500.08 following the completion of this transaction.
Also, JOSHUA MOLHO purchased 1,860 shares, netting a total of over 122,691 in proceeds.
Before that, Kelderman Kim had sold 13,392 shares from its account. In a trade valued at $1,035,013, the Chief Executive Officer traded Bio-Techne Corp shares for $77.29 each. Upon closing the transaction, the insider’s holdings decreased to 13,392 shares, worth approximately $1.89 million.
As published in a research note from KeyBanc Capital Markets on April 09, 2025, Bio-Techne Corp [TECH] has been rated down from an Overweight to a Sector weight. Analysts at Evercore ISI started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid March. As of February 19, 2025, Robert W. Baird has decreased its “an Outperform” rating to a “Neutral” for TECH. Earlier on May 22, 2024, Citigroup downgraded its rating. Their new recommendation was “a Neutral” for TECH stock which previously was a “a Buy”.
Analyzing TECH Stock Performance
During the last five days, there has been a surge of approximately 3.58%. Over the course of the year, Bio-Techne Corp shares have dropped approximately -32.90%. Shares of the company reached a 52-week high of $79.28 on 02/05/25 and a 52-week low of $46.01 on 04/21/25.
Support And Resistance Levels for Bio-Techne Corp (TECH)
According to the 24-hour chart, there is a support level at 47.88, which, if violated, would cause prices to drop to 47.43. In the upper region, resistance lies at 48.83. The next price resistance is at 49.33. RSI (Relative Strength Index) is 45.55 on the 14-day chart, showing neutral technical sentiment.
